Cardioplegia Solution del Nido Formula Recalled for Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling 10,480 bags of Cardioplegia Solution del Nido Formula nationwide due to missing validation data for decontamination cycles, creating potential sterility assurance risks.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a sterile product for critical cardiac use (intracardiac perfusion during surgery). Although no illnesses have been reported, lack of sterility assurance in such a critical application represents a risk-of-harm product that meets the High severity criterion.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 10,480 bags of Cardioplegia Solution del Nido Formula, a sterile solution used during cardiac surgery for intracardiac perfusion. The recall affects product distributed nationwide in the United States.
The manufacturer determined that validation data for decontamination cycles is lacking, which means the manufacturer cannot provide assurance that the product has been properly sterilized. This creates a potential contamination risk for a product that must be sterile for safe use.
The affected product includes multiple lot numbers with expiration dates from July through August 2023. Healthcare facilities should identify and quarantine affected inventory using the specific lot numbers listed in the recall notice.
The recalled product
- Product
- Cardioplegia Solution del Nido Formula, IV Bag, Total Volume = 1,052.8 mL, FOR INTRACARDIAC PERFUSION USE ONLY, PLASMA-LYTE A 1000 mL, Mannitol 20% 16.3 mL, Sodium Bicarbonate 8.4% 13 mL, Potassium Chloride 2 mEq/mL 13 mL, Magnesium Sulfate 4.06 mEq/mL 4 mL, Lidocaine 2% 6.5 mL,
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- contamination-risk
- missing-validation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 36-252365
- 36-252368
- 36-252369
- 36-253887
- 36-253888
- Exp. 8/1/2023
- 36-254404
- 36-254406
- 36-254407
- 36-254408
- 36-254409
- 36-254410
- Exp. 8/5/2023
- 36-255219
- 36-255220
- 36-255221
- 36-255222
- 36-255223
- Exp. 8/7/2023
- 36-255420
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27